UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study

Breast (Edinburgh), 2020-12, Vol.54, p.256-263

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

Scientific reports, 2020-07, Vol.10 (1), p.10757-10757, Article 10757

2020

Link zum Volltext

Verfügbarkeit prüfen

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

Blood, 2000-02, Vol.95 (3), p.802-806

2000

Link zum Volltext

Verfügbarkeit prüfen

High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation

Blood, 1998-05, Vol.91 (9), p.3148-3155

1998

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Journal of clinical oncology, 2021-10, Vol.39 (29), p.3242-3250

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer

The oncologist (Dayton, Ohio), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

British journal of cancer, 2019-12, Vol.121 (12), p.1001-1008

2019

Link zum Volltext

Verfügbarkeit prüfen

Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System

Journal of clinical oncology, 2000-01, Vol.18 (2), p.325-331

2000

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1010-1010

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-11-22: Clinical and biological efficacy of first line AI and palbociclib in ER+ HER2- MBC with detectable circulating ESR1 mutation prior to treatment initiation

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-22

2020

Link zum Volltext

Verfügbarkeit prüfen

Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors

The American journal of medicine, 1999-02, Vol.106 (2), p.191-197

1999

Link zum Volltext

Verfügbarkeit prüfen

Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.501-501

2014

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

British journal of haematology, 1998-10, Vol.103 (1), p.235-241

1998

Link zum Volltext

Verfügbarkeit prüfen

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

Blood, 2000-04, Vol.95 (7), p.2246-2252

2000

Link zum Volltext

Verfügbarkeit prüfen

Ab-initio molecular dynamics study of the interaction of aluminium clusters on a graphite surface

Surface science, 1995-07, Vol.331-333, p.697-702

Moullet, Isabelle

1995

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study

Bulletin du cancer, 2011-10, Vol.98 (9), p.E80-E89

2011

Link zum Volltext

Verfügbarkeit prüfen

Epoetin [beta] Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

Oncology, 2008-06, Vol.74 (1-2), p.112

2008

Link zum Volltext

Verfügbarkeit prüfen

Epoetin β Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

Oncology, 2008-01, Vol.74 (1-2), p.112-118

2008

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic therapy for choroidal metastasis from lung adenocarcinoma

Acta ophthalmologica Scandinavica, 2006-08, Vol.84 (4), p.552-554

2006

Link zum Volltext

Verfügbarkeit prüfen

High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation

Blood, 1998-05, Vol.91 (9), p.3148-3155

1998

Link zum Volltext

Verfügbarkeit prüfen

Alkali adsorption on Si(111) surfaces: ab initio molecular dynamics studies

Surface science, 1992-05, Vol.269-270, p.1000-1004

1992

Link zum Volltext

Verfügbarkeit prüfen

Si(111):Na: structural and electronic properties from ab initio molecular dynamics

Physical review. B, Condensed matter, 1992-07, Vol.46 (3), p.1842-1845

1992

Link zum Volltext

Verfügbarkeit prüfen

Correction: ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children—a systematic review and meta-analysis

Intensive care medicine, 2023-01, Vol.49 (1), p.128-129

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(34)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer

Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed

High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study

Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial

Abstract P5-11-22: Clinical and biological efficacy of first line AI and palbociclib in ER+ HER2- MBC with detectable circulating ESR1 mutation prior to treatment initiation

Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors

Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study

Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

Ab-initio molecular dynamics study of the interaction of aluminium clusters on a graphite surface

Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study

Epoetin [beta] Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

Epoetin β Once-Weekly Therapy in Anemic Patients with Solid Tumors and Non-Myeloid Hematological Malignancies Receiving Chemotherapy

Photodynamic therapy for choroidal metastasis from lung adenocarcinoma

High CD34+ cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation

Alkali adsorption on Si(111) surfaces: ab initio molecular dynamics studies

Si(111):Na: structural and electronic properties from ab initio molecular dynamics

Correction: ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children—a systematic review and meta-analysis

Suchergebnisse filtern